The tumor suppressor p53 binding protein 1 (53BP1) binds to the DNA-binding domain of p53 and enhances p53-mediated transcriptional activation. 53BP1 contains two breast cancer susceptibility gene 1 COOH terminus (BRCT) motifs, which are present in several proteins involved in DNA repair and/or DNA damage–signaling pathways. Thus, we investigated the potential role of 53BP1 in DNA damage–signaling pathways. Here, we report that 53BP1 becomes hyperphosphorylated and forms discrete nuclear foci in response to DNA damage. These foci colocalize at all time points with phosphorylated H2AX (γ-H2AX), which has been previously demonstrated to localize at sites of DNA strand breaks. 53BP1 foci formation is not restricted to γ-radiation but is also detected in response to UV radiation as well as hydroxyurea, camptothecin, etoposide, and methylmethanesulfonate treatment. Several observations suggest that 53BP1 is regulated by ataxia telangiectasia mutated (ATM) after DNA damage. First, ATM-deficient cells show no 53BP1 hyperphosphorylation and reduced 53BP1 foci formation in response to γ-radiation compared with cells expressing wild-type ATM. Second, wortmannin treatment strongly inhibits γ-radiation–induced hyperphosphorylation and foci formation of 53BP1. Third, 53BP1 is readily phosphorylated by ATM in vitro. Taken together, these results suggest that 53BP1 is an ATM substrate that is involved early in the DNA damage–signaling pathways in mammalian cells.
Skip Nav Destination
Article navigation
30 April 2001
Article|
April 30 2001
Tumor Suppressor P53 Binding Protein 1 (53bp1) Is Involved in DNA Damage–Signaling Pathways
In Special Collection:
JCB65: DNA Replication and Repair
Irene Rappold,
Irene Rappold
aDivision of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905
Search for other works by this author on:
Kuniyoshi Iwabuchi,
Kuniyoshi Iwabuchi
aDivision of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905
Search for other works by this author on:
Takayasu Date,
Takayasu Date
bDepartment of Biochemistry, Kanazawa Medical University, Ishikawa 920-0293, Japan
Search for other works by this author on:
Junjie Chen
Junjie Chen
aDivision of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905
Search for other works by this author on:
Irene Rappold
aDivision of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905
Kuniyoshi Iwabuchi
aDivision of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905
Takayasu Date
bDepartment of Biochemistry, Kanazawa Medical University, Ishikawa 920-0293, Japan
Junjie Chen
aDivision of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905
Abbreviations used in this paper: ATM, ataxia telangiectasia mutated; BRCA1, breast cancer susceptibility gene 1; BRCT, BRCA1 COOH terminus; DNA-PK, DNA-dependent protein kinase; 53BP1, binding protein 1; GST, glutathione S-transferase; PI3K, phosphatidylinositol 3–kinase.
Received:
October 24 2000
Revision Requested:
March 23 2001
Accepted:
March 26 2001
Online ISSN: 1540-8140
Print ISSN: 0021-9525
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Cell Biol (2001) 153 (3): 613–620.
Article history
Received:
October 24 2000
Revision Requested:
March 23 2001
Accepted:
March 26 2001
Connected Content
This article has been corrected
Correction
Citation
Irene Rappold, Kuniyoshi Iwabuchi, Takayasu Date, Junjie Chen; Tumor Suppressor P53 Binding Protein 1 (53bp1) Is Involved in DNA Damage–Signaling Pathways. J Cell Biol 30 April 2001; 153 (3): 613–620. doi: https://doi.org/10.1083/jcb.153.3.613
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Connected Content
Advertisement
Advertisement